AI Product Leader, Manager & Builder
PhD · 9+ Years of Experience in AI
I take AI from research to reality — and I still build the thing myself. A decade spanning ML research, product strategy, funding, prospective trials, and EU MDR regulatory filings has given me a rare vantage point. I understand AI deeply enough to push it forward, and practically enough to know what's worth building.
PhD · AI
I am an AI Product Leader, Manager and Researcher with a PhD in Medical Technology from NTNU and 9+ years spent where machine learning, biomedical engineering, and healthcare product delivery intersect. I bring a rare combination of deep technical fluency in machine and deep learning with the product, regulatory, and stakeholder skills needed to turn research and ideas into something that actually ships.
My flagship project, PROVIZ, took an AI decision-support system for prostate MRI from early-stage research (TRL 2) to a clinically validated, EU MDR-aligned product (TRL ~7). Along the way, I secured $800K+ in grants, designed and ran a prospective clinical study with 115+ patients, authored regulatory documentation, and built collaborative pipelines with radiologists, IT engineers, and medtech companies. More recently I have been shipping smaller, faster projects solo: an AI regulatory assistant and a bilingual PWA, both live today.
CNNs, GANs, XGBoost, Radiomics, nnU-Net.
Not just a PM who talks about AI, but someone who builds it.
Authored risk management, clinical evaluation, and technical files for SaMD under EU MDR and GDPR.
A leader with deep regulatory expertise.
Moved PROVIZ from TRL 2 to ~7, conducted prospective clinical study, initiated 10+ industry partnership talks.
Someone who already brought AI products to light.
PROVIZ is a fully automated AI decision-support system that analyses prostate MRI, outputs cancer probability & detection maps, and assists radiologists in detecting clinically significant tumours. I led/co-led this system from an early research project to a prospectively validated, EU MDR-aligned clinical software.
Selected and helped in the development of deep learning and radiomics pipelines for prostate cancer detection, segmentation, and normalization on biparametric MRI.
Formalized product concept, conducted market analysis, and filed international patent PCT/EP2023/061976 through NTNU TTO.
Authored complete EU MDR technical documentation for SaMD (Software as a Medical Device), obtained ethics and regulatory approvals.
Designed and ran prospective clinical study (NCT06000046) at St. Olavs Hospital, integrating PROVIZ into routine radiology workflow.
A bilingual RAG assistant that gives grounded, source-cited answers to health-AI regulatory questions across the Gulf, Europe, and the US. PDF ingestion, ChromaDB retrieval, Groq/Llama generation, and a Streamlit front end.
An installable PWA for tracking daily customer follow-up calls and payment collection — multi-currency balances, check handling, an AI-generated call plan, and a natural-language Q&A assistant over your own data. Zero backend, runs entirely in the browser, full RTL/LTR mirroring.
Automated dual-reference tissue normalization of T2-weighted prostate MRI images using object recognition. Available via pip install pyAutoRef.
Fully automated quality control system for prostate segmentation on T2W MRI. Generates quality scores and classes for automated segmentation pipelines. Also available via pip.
Generative Adversarial Networks for automated prostate cancer detection on biparametric MRI. Research collaboration benchmarking GAN architectures for cancer detection.
Investigation of radiomics feature reproducibility and the impact of deep learning-based prostate segmentation variations on downstream analysis and clinical studies.
Consortium member in the Prostate Imaging Cancer AI initiative — a major international benchmarking challenge built on 10,000+ MRI exams from 9,000+ patients across 4 European centres, involving 830+ AI developers from 50+ countries.
18+ journal papers · 30+ conference abstracts · 1 book chapter · H-index 9
Wrap-up of Norway's national biotech accelerator, part of the same Digital Life Norway innovation network that has supported PROVIZ's own commercialization programmes.
National tech-news coverage of PROVIZ's funding round, with the team's plans for clinical trials and spinning out a company within the year.
PROVIZ secured 2.5M NOK combined — including a renewed Digital Life Norway Innovation Roadmap pilot — to build out its regulatory and clinical commercialization path.
NTNU Discovery awarded 4.6M NOK across six research-based startup projects, including PROVIZ, to help translate research into companies.
PROVIZ selected as one of eight Nordic research teams for REACH, a six-month research-commercialization accelerator with in-person and virtual programming in Silicon Valley.
Feature on PROVIZ, the AI-powered MRI software developed at NTNU to help radiologists detect prostate cancer and reduce unnecessary biopsies.
I am open to opportunities in AI product leadership, management, and translational AI research. Whether you are building a team, exploring collaboration, or want to discuss AI in healthcare or translation,I would love to hear from you.